NCT06800716View on ClinicalTrials.gov

Impella Reverse Remodeling in End-Stage Heart Failure

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 4, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2027

Conditions
Heart FailureCardiomyopathy
Trial Locations (1)

10032

RECRUITING

Columbia University, New York

Sponsors

Collaborators (1)

Abiomed Inc.
All Listed Sponsors
collaborator

Abiomed Inc.

INDUSTRY

lead

Columbia University

OTHER

NCT06800716 - Impella Reverse Remodeling in End-Stage Heart Failure | Biotech Hunter | Biotech Hunter